MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Da Silva Jorge Santos Sells 20,000 Shares

MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) CEO Da Silva Jorge Santos sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $57.44, for a total transaction of $1,148,800.00. Following the transaction, the chief executive officer now owns 3,107,554 shares […]

Related Keywords

United States ,America ,Silva Jorge Santos ,Stifel Nicolaus ,Moonlake Immunotherapeutics ,Moonlake Immunotherapeutics Company Profile ,America Corp ,Securities Exchange Commission ,Tower Research Capital ,Wolfe Research ,Osaic Holdings Inc ,Goldman Sachs Group Inc ,Cantor Fitzgerald ,Get Free Report ,Exchange Commission ,Research Capital ,Sachs Group ,Nasdaq Mltx ,Mltx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,